Literature DB >> 19734443

Approach to the patient with possible Cushing's syndrome.

Marco Boscaro1, Giorgio Arnaldi.   

Abstract

Clinical decision making for patients with suspect hypercortisolism involves a complex diagnostic assessment. Cushing's syndrome remains one of the most challenging endocrine pathologies. Most clinical features overlap with those of common diseases found in the general population, and some patients have an atypical clinical presentation with only isolated symptoms. Recently, several studies have suggested that the prevalence of Cushing's syndrome is higher than previously thought. Therefore, efficient screening tests are needed to identify the few uncovered patients also among unselected high-risk ambulatory patients with disorders potentially related to cortisol excess. The recommended diagnostic tests are 24-h urinary free cortisol, 1-mg overnight dexamethasone suppression test, and late-night salivary cortisol. Once the diagnosis of Cushing's syndrome is established, the next step is the measurement of plasma ACTH. Then, dynamic test and appropriate imaging procedures are the most useful noninvasive investigations for the differential diagnosis. Patients with Cushing's disease are generally responsive to the CRH test and to high-dose glucocorticoid feedback. Bilateral inferior petrosal sinus sampling is considered the gold standard for establishing the origin of ACTH secretion, and it is recommended in patients with ACTH-dependent Cushing's syndrome whose clinical, biochemical, or radiological studies are discordant or equivocal. The present clinical case shows that even if rare, the ectopic ACTH secretion should be considered also in those cases where the pretest probability is low. The management of Cushing's syndrome depends on the exact knowledge of its various causes, paying attention to the many potential diagnostic pitfalls. The choice of test, the modality of specimen collection (blood, urine, and saliva), the quality of measurement (assay methodology and standardization), and close dialogue among endocrinologists, chemical pathologists, and neuroradiologists are key factors for optimal care of patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19734443     DOI: 10.1210/jc.2009-0612

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  65 in total

1.  Diagnostic performance of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay in obese and overweight patients referred to exclude Cushing's syndrome.

Authors:  Zhanna E Belaya; Alexander V Iljin; Galina A Melnichenko; Liudmila Y Rozhinskaya; Natalia V Dragunova; Larisa K Dzeranova; Svetlana A Butrova; Ekaterina A Troshina; Ivan I Dedov
Journal:  Endocrine       Date:  2012-03-25       Impact factor: 3.633

2.  Current laboratory requirements for adrenocorticotropic hormone and renin/aldosterone sample handling are unnecessarily restrictive.

Authors:  Ali J Chakera; Timothy J McDonald; Bridget A Knight; Bijay Vaidya; Angus G Jones
Journal:  Clin Med (Lond)       Date:  2017-02       Impact factor: 2.659

Review 3.  Conventional and Nuclear Medicine Imaging in Ectopic Cushing's Syndrome: A Systematic Review.

Authors:  Andrea M Isidori; Emilia Sbardella; Maria Chiara Zatelli; Mara Boschetti; Giovanni Vitale; Annamaria Colao; Rosario Pivonello
Journal:  J Clin Endocrinol Metab       Date:  2015-09       Impact factor: 5.958

4.  Intraoperative multiple-staged resection and tumor tissue identification using frozen sections provide the best result for the accurate localization and complete resection of tumors in Cushing's disease.

Authors:  Jung Soo Lim; Seung Ku Lee; Se Hoon Kim; Eun Jig Lee; Sun Ho Kim
Journal:  Endocrine       Date:  2011-06-19       Impact factor: 3.633

Review 5.  Cushing's syndrome: why is diagnosis so difficult?

Authors:  David C Aron
Journal:  Rev Endocr Metab Disord       Date:  2010-06       Impact factor: 6.514

6.  Selective inferior petrosal sinus sampling without venous outflow diversion in the detection of a pituitary adenoma in Cushing's syndrome.

Authors:  Lukas Andereggen; Gerhard Schroth; Jan Gralla; Rolf Seiler; Luigi Mariani; Jürgen Beck; Hans-Rudolf Widmer; Robert H Andres; Emanuel Christ; Christoph Ozdoba
Journal:  Neuroradiology       Date:  2011-08-02       Impact factor: 2.804

7.  Measurement of urinary free cortisol by LC-MS-MS: adoption of a literature reference range and comparison with our current immunometric method.

Authors:  L Bianchi; B Campi; M R Sessa; G De Marco; E Ferrarini; R Zucchi; C Marcocci; P Vitti; L Manetti; A Saba; P Agretti
Journal:  J Endocrinol Invest       Date:  2019-04-22       Impact factor: 4.256

Review 8.  Ectopic ACTH-secreting pituitary adenomas within the sphenoid sinus.

Authors:  Philip C Johnston; Laurence Kennedy; Robert J Weil; Amir H Hamrahian
Journal:  Endocrine       Date:  2014-06-14       Impact factor: 3.633

Review 9.  Psychosomatic aspects of Cushing's syndrome.

Authors:  Nicoletta Sonino; Francesco Fallo; Giovanni A Fava
Journal:  Rev Endocr Metab Disord       Date:  2010-06       Impact factor: 6.514

10.  Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors.

Authors:  Armando Tripodi; Concetta T Ammollo; Fabrizio Semeraro; Mario Colucci; Elena Malchiodi; Elisa Verrua; Emanuele Ferrante; Giorgio Arnaldi; Laura Trementino; Lidia Padovan; Veena Chantarangkul; Flora Peyvandi; Giovanna Mantovani
Journal:  Endocrine       Date:  2016-07-22       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.